The Relative Strength (RS) Rating for Globus Medical entered a new percentile Tuesday, with an increase from 74 to 84.
This unique rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
History shows that the best stocks often have an RS Rating of above 80 as they launch their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
While now is not an ideal time to jump in, see if the stock manages to establish and enter a buying range in heavy volume.
The company reported 40% EPS growth last quarter, while sales growth came in at 7%.
Globus Medical holds the No. 12 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
